Published: May 21, 2024, 04:10 IST | Updated: May 21, 2024, 04:10 IST
Less than a month ago, Neuralink announced that its brain-computer interface had been approved for human testing. However, Reuters has now reported that the U.S. Food and Drug Administration (FDA) discovered that the company had failed to keep records of animal experiments. The FDA also said that there were some issues with quality control. Investigators found quality control lapses at Neuralink’s animal research facilities in California. However, similar inspections of facilities in Texas found no problems.